According to Gram Research analysis, Jingling Granules—a traditional Chinese medicine formula—reduced atherosclerotic plaque buildup in mice by activating cellular cleanup processes and protecting blood vessel cells from dying. A 2026 study in Scientific Reports found the formula works by inhibiting the mTOR pathway, which enhances autophagy while suppressing cell death. However, these results come from animal and cell studies only; human clinical trials are needed before doctors can recommend this treatment for heart disease prevention.
Researchers discovered that Jingling Granules, a traditional Chinese medicine formula, may help prevent atherosclerosis—a dangerous buildup of plaque in arteries. In a study published in Scientific Reports, scientists found that this formula works by activating a cellular cleanup process called autophagy while protecting blood vessel cells from dying. When tested in mice fed a high-fat diet, Jingling Granules reduced plaque buildup, improved cholesterol levels, and decreased inflammation. The research suggests this ancient remedy could offer a new way to treat early-stage heart disease, though human studies are still needed to confirm these benefits.
Key Statistics
A 2026 study published in Scientific Reports found that Jingling Granules moderately reduced atherosclerotic lesion area in high-fat diet-fed mice while simultaneously improving serum lipid profiles and suppressing systemic inflammation.
Research reviewed by Gram shows that Jingling Granules enhanced autophagic flux and attenuated endothelial cell apoptosis in mice by downregulating phosphorylated mTOR, a key cellular signaling molecule.
In laboratory studies of human blood vessel cells, Jingling Granules promoted autophagy and reduced apoptosis, but these protective effects were completely abolished when researchers artificially activated the mTOR pathway using the chemical MHY1485.
The Quick Take
- What they studied: Whether a traditional Chinese medicine called Jingling Granules could prevent or slow down atherosclerosis (clogged arteries) by activating a cellular cleaning process and protecting blood vessel cells.
- Who participated: The study used mice genetically engineered to develop atherosclerosis when fed a high-fat diet, and human blood vessel cells grown in laboratory conditions. No human patients were directly studied.
- Key finding: Jingling Granules reduced atherosclerotic plaque buildup in mice, improved their cholesterol levels, and decreased inflammation by activating autophagy (cellular cleanup) and protecting blood vessel cells from dying.
- What it means for you: This research suggests Jingling Granules might help prevent heart disease in people with early-stage atherosclerosis, but human clinical trials are needed before doctors can recommend it. Talk to your healthcare provider before trying any new supplements.
The Research Details
Scientists conducted two types of experiments to understand how Jingling Granules work. First, they fed mice a high-fat diet to trigger atherosclerosis, then gave some mice Jingling Granules while others received no treatment. They measured plaque buildup, cholesterol levels, and inflammation markers in the mice’s blood. Second, they grew human blood vessel cells in petri dishes, exposed them to palmitic acid (a harmful fat), and treated some with Jingling Granules to see how the cells responded. They also used special chemicals to block the mTOR pathway—a cellular signaling system—to confirm this pathway was responsible for the formula’s protective effects.
This research approach is important because it combines animal studies with laboratory cell studies to understand both how a treatment works in a living body and the specific molecular mechanisms involved. By using mice that naturally develop atherosclerosis and then testing the formula’s effects on human blood vessel cells, researchers could confirm that Jingling Granules works through the same pathway in both systems. This two-pronged approach strengthens confidence in the findings before moving to human trials.
The study was published in Scientific Reports, a peer-reviewed journal, which means other scientists reviewed the work before publication. The researchers used multiple measurements (cholesterol, inflammation, plaque size) rather than relying on a single outcome. However, the study did not include human patients, only animals and cells, so results may not directly translate to people. The exact sample size of mice used was not specified in the abstract, which limits our ability to assess statistical power.
What the Results Show
In mice fed a high-fat diet, Jingling Granules produced three main benefits. First, it moderately reduced the size of atherosclerotic plaques—the dangerous buildup of material inside arteries that causes heart disease. Second, it improved the mice’s serum lipid profiles, meaning cholesterol and triglyceride levels improved. Third, it suppressed systemic inflammation, reducing harmful inflammatory markers throughout the body. These improvements occurred because Jingling Granules activated autophagy, a cellular cleanup process that removes damaged components, while simultaneously protecting blood vessel cells from apoptosis (programmed cell death). The formula worked by inhibiting the mTOR pathway, a cellular signaling system that normally suppresses autophagy.
When researchers tested Jingling Granules on human blood vessel cells exposed to palmitic acid (a harmful saturated fat), the formula promoted autophagy and reduced cell death. Importantly, when they used a chemical called MHY1485 to artificially activate the mTOR pathway, it completely blocked Jingling Granules’ protective effects. This finding confirmed that the mTOR pathway is essential for how the formula works—without inhibiting mTOR, the formula cannot activate autophagy or protect cells.
This research builds on earlier observations that Jingling Granules have vascular protective effects, but it’s the first study to explain the specific mechanisms involved. Previous research suggested autophagy and cell protection were important in preventing atherosclerosis, but this study directly demonstrates that Jingling Granules achieves these effects by targeting the mTOR pathway. The findings align with other research showing that enhancing autophagy and reducing cell death are promising strategies for treating cardiovascular disease.
This study has several important limitations. It only tested Jingling Granules in mice and laboratory cells, not in human patients, so results may not directly apply to people. The study did not specify how many mice were used, making it difficult to assess whether the sample size was large enough to detect real effects. The research focused on early-stage atherosclerosis, so it’s unclear whether the formula would work for advanced disease. Additionally, the study did not compare Jingling Granules to standard heart disease medications, so we don’t know if it’s more or less effective than existing treatments. Long-term safety and effectiveness in humans remain unknown.
The Bottom Line
Based on this research, Jingling Granules shows promise as a potential treatment for early-stage atherosclerosis, but the evidence is currently limited to animal and cell studies. Confidence level: LOW for human use (requires clinical trials). If you have atherosclerosis or cardiovascular risk factors, consult your doctor before considering Jingling Granules. Do not stop taking prescribed heart medications without medical guidance. This formula may be worth discussing with a healthcare provider who specializes in integrative medicine, but it should complement—not replace—proven treatments like statins and lifestyle changes.
People with early-stage atherosclerosis, high cholesterol, or significant cardiovascular disease risk may find this research interesting. However, this study does not yet provide evidence strong enough to recommend Jingling Granules to the general public. People taking blood thinners or other cardiovascular medications should consult their doctor before trying this formula, as interactions are possible. Pregnant women and children should avoid this supplement until human safety data is available.
If Jingling Granules were to be tested in humans, improvements in cholesterol and inflammation markers might appear within weeks to months, similar to other cardiovascular interventions. However, reductions in atherosclerotic plaque typically take months to years to become measurable. Realistic expectations would be gradual improvements over 3-6 months of consistent use, assuming human studies eventually confirm the animal findings.
Frequently Asked Questions
Can Jingling Granules prevent heart disease?
Research shows Jingling Granules reduced plaque buildup in mice by activating cellular cleanup and protecting blood vessel cells. However, only animal studies exist so far—human clinical trials are needed before doctors can recommend it for heart disease prevention.
How does Jingling Granules work to prevent atherosclerosis?
The formula inhibits the mTOR pathway, which activates autophagy (cellular cleanup) and prevents blood vessel cells from dying. This combination slows plaque accumulation and reduces inflammation in arteries.
Is Jingling Granules safe to take with heart medications?
This study did not test interactions with other medications. Consult your doctor before combining Jingling Granules with blood thinners, statins, or other cardiovascular drugs, as potential interactions are unknown.
When will Jingling Granules be available as a heart disease treatment?
Human clinical trials are required before regulatory approval. Based on typical drug development timelines, this could take 5-10 years. Currently, Jingling Granules may be available as a supplement in some regions, but evidence for human use remains limited.
Should I stop taking my cholesterol medication and try Jingling Granules instead?
No. Do not stop prescribed heart medications without medical guidance. Proven treatments like statins have strong human evidence. Jingling Granules might complement—not replace—your current medications, but only with doctor approval.
Want to Apply This Research?
- If a user is interested in Jingling Granules (with doctor approval), track weekly cholesterol levels, blood pressure readings, and inflammation markers (like C-reactive protein) through periodic lab work. Record these measurements in the app to monitor trends over 3-month intervals.
- Users could log daily Jingling Granules intake alongside heart-healthy behaviors: minutes of exercise, servings of vegetables, and alcohol consumption. This creates a comprehensive picture of cardiovascular health efforts and helps identify which combination of habits produces the best results.
- Establish a quarterly check-in system where users review their lipid panel results, blood pressure trends, and inflammation markers. Compare these metrics to baseline measurements taken before starting Jingling Granules. Share this data with healthcare providers to ensure the supplement is working safely alongside prescribed medications.
This article summarizes research findings from animal and laboratory studies. Jingling Granules have NOT been approved by the FDA for treating atherosclerosis or heart disease in humans. Do not use this information to self-diagnose or self-treat cardiovascular conditions. Consult your healthcare provider before starting any new supplement, especially if you take blood thinners, cholesterol medications, or have existing heart disease. This research does not replace medical advice, diagnosis, or treatment from qualified healthcare professionals. Results from animal studies may not translate to humans.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.